BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 21383248)

  • 1. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
    Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
    J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide.
    Morishima Y; Ishii Y; Kimura T; Shibuya A; Shibuya K; Hegab AE; Iizuka T; Kiwamoto T; Matsuno Y; Sakamoto T; Nomura A; Taniguchi M; Sekizawa K
    Eur J Immunol; 2005 Oct; 35(10):2803-14. PubMed ID: 16163669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
    J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.
    Hachem P; Lisbonne M; Michel ML; Diem S; Roongapinun S; Lefort J; Marchal G; Herbelin A; Askenase PW; Dy M; Leite-de-Moraes MC
    Eur J Immunol; 2005 Oct; 35(10):2793-802. PubMed ID: 16180255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
    Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
    J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation.
    Vultaggio A; Nencini F; Pratesi S; Petroni G; Romagnani S; Maggi E
    Allergy; 2012 Oct; 67(10):1223-32. PubMed ID: 22882449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production.
    Bilenki L; Yang J; Fan Y; Wang S; Yang X
    Eur J Immunol; 2004 Feb; 34(2):345-54. PubMed ID: 14768039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
    Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H
    Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.
    Araujo LM; Lefort J; Nahori MA; Diem S; Zhu R; Dy M; Leite-de-Moraes MC; Bach JF; Vargaftig BB; Herbelin A
    Eur J Immunol; 2004 Feb; 34(2):327-35. PubMed ID: 14768037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant NKT cells act as an adjuvant to enhance Th2 inflammatory response in an OVA-induced mouse model of asthma.
    Nie H; Yang Q; Zhang G; Wang A; He Q; Liu M; Li P; Yang J; Huang Y; Ding X; Yu H; Hu S
    PLoS One; 2015; 10(4):e0119901. PubMed ID: 25830340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.
    Hammad H; de Vries VC; Maldonado-Lopez R; Moser M; Maliszewski C; Hoogsteden HC; Lambrecht BN
    Clin Exp Allergy; 2004 Dec; 34(12):1834-40. PubMed ID: 15663556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
    KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W
    Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
    J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model.
    Kim JO; Kim DH; Chang WS; Hong C; Park SH; Kim S; Kang CY
    J Allergy Clin Immunol; 2004 Dec; 114(6):1332-8. PubMed ID: 15577831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
    Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
    Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corticosteroid on the expression of thymus and activation-regulated chemokine in a murine model of allergic asthma.
    Kurokawa M; Kokubu F; Matsukura S; Kawaguchi M; Ieki K; Suzuki S; Odaka M; Watanabe S; Takeuchi H; Akabane T; Asano K; Iwase M; Honma I; Adachi M
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():60-8. PubMed ID: 15947487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IL-4/IL-13 does not enhance the efficacy of allergen immunotherapy in murine allergic airway inflammation.
    Gogishvili T; Hahn C; Meinhard J; Hohaus A; Erb K; Sebald W; Bröcker EB; Grunewald SM
    Int Arch Allergy Immunol; 2007; 142(2):165-74. PubMed ID: 17077644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.